Flow launches brain stimulation headset to treat depression in the UK

During brain stimulation, patients receive videos and advice about depression symptoms, focused on sleep, nutrition, fitness, and meditation via the app (Image: Flow)

Flow, a Malmö, Sweden-based medical device company Flow, announced that it is launching its brain stimulation headset and therapy app to treat depression in the UK.

Mental illness affects nearly one in four adults in the UK, and suicide is the most common cause of death for men aged 20-49 years in England and Wales.

Flow’s technology has similar outcomes as antidepressants, but with fewer side effects, reports EU startups.

Paired with a behavioral therapy app, Flow’s headset delivers low levels of transcranial direct current stimulation (tDCS) aimed at the user’s left frontal lobe. According to the company, people diagnosed with depression often have lower neural activity in this region of the brain, which helps govern certain cognitive skills and emotional expression.

“It works by sending a weak electric current, the equivalent of a 9-volt battery, into the frontal parts of the brain. The result is increased activity in the left part of the frontal lobe and decreased activity in the right part of the brain,” Flow said on its website.

During brain stimulation, the free app provides videos and advice about depression, and techniques for reducing symptoms focused on sleep, nutrition, fitness, and meditation. This is informed by expert knowledge in sleep, nutrition, fitness, and medication.

Image: Flow

The typical course of treatment with the Flow headset lasts for 30 minutes per brain-stimulation session, with 18 sessions over six weeks. Continued treatment will then take place once or twice a week.

“We want to support the improvement of the current standard of care for people living with depression by increasing treatment choice and empowering patients to self-manage their symptoms at home with effective, non-pharmacological alternatives,” said Daniel Mansson, co-founder and CEO of Flow.

People using Flow’s treatment should not stop their current therapy, the company warns, and it is not recommended for pregnant women or people under 18.

The headset retails for £399 (about $500 U.S.).

Source: www.wearable-technologies.com

Related posts

Examining ethical issues surrounding wearable brain devices marketed to consumers


NeuroMetrix restructuring business after Q2 2019 results show weak performance of Quell pain relief wearable


Washable, wearable battery-like devices could be woven directly into clothes